Journal articleEur Rev Med Pharmacol Sci2020
Hsa-miR-4730 as a new and potential diagnostic and prognostic indicators for pancreatic cancer.
- Journal
- Eur Rev Med Pharmacol Sci
- Published
- 1 September 2020
- Citations
- 8
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Objective Pancreatic cancer is a gastrointestinal tumor with the highest malignancy and few diagnostic and prognostic markers. Patients with disease have a 5-year survival rate that is not more than 10%. … Excerpt only: this text is the publisher’s. Read it in full at the source.